Osteopenia in rheumatology practice: pathogenesis and therapy.

Area of Science:

• Bone metabolism and endocrine disorders

Background:

• Postmenopausal osteoporosis results from decreased bone mass, calcium intake, and estrogen.
• Corticosteroid use can decrease intestinal calcium absorption, leading to osteopenia.
• Rheumatoid arthritis is associated with diffuse osteopenia and increased bone metabolic activity.

Purpose of the Study:

• To discuss therapeutic strategies for postmenopausal osteoporosis.
• To explore the mechanisms and potential treatments for corticosteroid-induced osteopenia.
• To describe the characteristics of osteopenia in rheumatoid arthritis.

Main Methods:

• Literature review of existing studies on osteoporosis and osteopenia.
• Discussion of various therapeutic agents including calcium, estrogen, fluoride, anabolic steroids, and calcitonin.
• Analysis of the role of vitamin D and calcium in managing corticosteroid-induced bone loss.

Main Results:

• Several therapeutic options exist for postmenopausal osteoporosis.
• Supplemental vitamin D and calcium may mitigate corticosteroid-induced osteopenia.
• Osteopenia in rheumatoid arthritis is a systemic process.

Conclusions:

• Effective management strategies are available for various forms of osteopenia.
• Further research may elucidate optimal treatment protocols for bone loss conditions.
• Understanding the pathogenesis of different osteopenias is crucial for targeted therapy.